BIODESIX, INC. Increase (Decrease) in Accounts Receivable
BIODESIX, INC. (BDSX) reported Increase (Decrease) in Accounts Receivable of $194.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- BIODESIX, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$294.00K.
- BIODESIX, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $488.00K.
- BIODESIX, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$3.61M, a 460.44% decline year-over-year.
- BIODESIX, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $5.22M.
- BIODESIX, INC. increase (decrease) in accounts receivable for fiscal 2025 was $531.00K, a 70.68% decline from fiscal 2024.
- BIODESIX, INC. increase (decrease) in accounts receivable for fiscal 2024 was $1.81M, a 61.62% decline from fiscal 2023.
- BIODESIX, INC. increase (decrease) in accounts receivable for fiscal 2023 was $4.72M, a 214.32% increase from fiscal 2022.
- BIODESIX, INC. increase (decrease) in accounts receivable for fiscal 2022 was $1.50M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $194.00K 10-Q · filed 2026-08-05 | -$3.41M derived: sum of 3 quarters · filed 2026-08-05 | $1.81M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $488.00K 10-Q · filed 2026-05-04 | -$3.12M derived: sum of 2 quarters · filed 2026-05-04 | $2.10M derived: sum of 3 quarters · filed 2026-05-04 | $1.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.62M derived: sum of 2 quarters · filed 2026-02-26 | $1.44M derived: sum of 3 quarters · filed 2026-08-05 | $531.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $5.04M derived: sum of 2 quarters · filed 2026-08-05 | $4.14M 10-Q · filed 2025-11-03 | $5.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.08M 10-Q · filed 2026-08-05 | -$84.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.94M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$904.00K 10-Q · filed 2026-05-04 | $97.00K derived: sum of 2 quarters · filed 2026-05-04 | -$1.76M derived: sum of 3 quarters · filed 2026-05-04 | -$1.44M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$858.00K derived: sum of 2 quarters · filed 2026-02-26 | -$533.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.81M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$1.53M derived: sum of 2 quarters · filed 2025-11-03 | $810.00K 10-Q · filed 2025-11-03 | $4.35M derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $325.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.67M 10-Q · filed 2025-08-07 | $6.21M derived: sum of 3 quarters · filed 2025-08-07 | $7.97M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $2.34M 10-Q · filed 2025-05-13 | $5.88M derived: sum of 2 quarters · filed 2025-05-13 | $7.64M derived: sum of 3 quarters · filed 2025-05-13 | $7.03M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $5.30M derived: sum of 2 quarters · filed 2025-03-03 | $4.68M derived: sum of 3 quarters · filed 2025-03-03 | $4.72M 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $1.15M derived: sum of 2 quarters · filed 2024-11-01 | $1.18M 10-Q · filed 2024-11-01 | $1.91M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$613.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$580.00K 10-Q · filed 2024-08-07 | $156.00K derived: sum of 3 quarters · filed 2024-08-07 | -$836.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $33.00K 10-Q · filed 2024-05-08 | $769.00K derived: sum of 2 quarters · filed 2024-05-08 | -$223.00K derived: sum of 3 quarters · filed 2024-05-08 | $1.46M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $736.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$256.00K derived: sum of 2 quarters · filed 2024-03-01 | $1.42M derived: sum of 3 quarters · filed 2024-03-01 | $1.50M 10-K · filed 2024-03-01 |
| 2022-09-30 | -$992.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $687.00K derived: sum of 2 quarters · filed 2023-11-07 | $765.00K 10-Q · filed 2023-11-07 | $1.64M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.76M 10-Q · filed 2023-08-07 | $2.63M derived: sum of 3 quarters · filed 2023-08-07 | $133.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $78.00K 10-Q · filed 2023-05-11 | $951.00K derived: sum of 2 quarters · filed 2023-05-11 | -$1.55M derived: sum of 3 quarters · filed 2023-05-11 | -$14.63M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$1.62M derived: sum of 2 quarters · filed 2023-03-06 | -$14.71M derived: sum of 3 quarters · filed 2023-03-06 | -$11.45M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$15.58M derived: sum of 2 quarters · filed 2022-11-03 | -$12.33M 10-Q · filed 2022-11-03 | -$2.24M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$13.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$9.83M 10-Q · filed 2022-08-04 | $261.00K derived: sum of 3 quarters · filed 2022-08-04 | $2.71M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $3.26M 10-Q · filed 2022-05-11 | $13.35M derived: sum of 2 quarters · filed 2022-05-11 | $15.80M derived: sum of 3 quarters · filed 2022-05-11 | $16.03M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $10.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $12.54M derived: sum of 2 quarters · filed 2022-03-14 | $12.77M derived: sum of 3 quarters · filed 2022-03-14 | $10.31M 10-K · filed 2022-03-14 |
| 2020-09-30 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.68M derived: sum of 2 quarters · filed 2021-11-15 | $217.00K 10-Q · filed 2021-11-15 | $3.88M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$2.23M 10-Q · filed 2021-08-10 | $1.43M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$2.46M 10-Q · filed 2021-05-11 | $1.20M derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $3.65M 10-K · filed 2021-03-16 | ||
| 2019-09-30 | -$17.00K 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |